We hypothesized that the lipid second messenger, ceramide, and microtubule-
directed chemotherapeutic agents might engage converging pathways in induci
ng apoptosis. Our studies demonstrated that simultaneous treatment of Jurka
t cells with paclitaxel and ceramide enhanced paclitaxel-induced cell growt
h inhibition. Cell cycle analysis indicated a significant increase in the h
ypodiploid population over that observed with paclitaxel treatment alone. M
orphologic evaluation and a TUNEL assay confirmed a dramatic increase in ap
optosis in Jurkat cells treated with the combination of these two agents. T
his is the first demonstration that paclitaxel and ceramide interact in a s
upra-additive manner to decrease leukemic T-cell growth, suggesting a possi
ble application of paclitaxel and ceramide in combination therapy. (C) 1999
Elsevier Science Ltd. All rights reserved.